Introduction {#s1}
============

Night-shift work is increasingly frequent among both full-time and part-time workers worldwide. Night-shift workers have to face the biological challenges of work shifts, light at night and altered circadian rhythm cycles. These challenges, as well as alterations in daily life and activity may introduce potential harms to night workers. In different employment sectors today, the number of people working overtime or on a night shift has been increasing, especially in transportation, health care, and manufacturing ([@B1]). Surveys of Americans, Europeans and Australians have shown that 15--30% of adults were engaged in shift work experience, and more than 30% of them fell asleep at work at least once a week ([@B2]). Apart from an increased risk of work-related injury, night-shift workers have a greater chance of having long-term disorders. Currently, epidemiological evidences indicated that night-shift work is recognized to be associated with increased susceptibilities to cancer ([@B3], [@B4]).

The International Agency for Research on Cancer (IARC) has defined that night-shift work is probably carcinogenic to humans (IARC Group 2A) ([@B5]). Further studies have proposed the followings as a potential mechanism of carcinogenicity of night-shift work as: (1) circadian rhythm disruption, (2) melatonin suppression due to exposure to light at night, (3) physiological changes, (4) lifestyle disturbances, and (5) decreased vitamin D levels (resulting from lack of sunlight) ([@B6]). However, studies focusing on the association between night-shift work and cancer risks have reached contradictory conclusions. Even though several systematic reviews and meta-analyses have been conducted, they presented inconsistent findings ([@B7]). Nine reviews reported that night work may be positively associated with breast cancer, skin cancer, prostate cancer, colorectal cancer, and lung cancer ([@B2], [@B8]--[@B15]), while four reviews reported slightly elevated but statistically insignificant results, among which the review published in 2017 included nine studies and 2,570,790 participants ([@B2]), the review in 2016 included ten studies and 4,660 breast cancer patients ([@B16]), the review in 2013 included 16 studies and 1,444,881 participants ([@B17]), and another review in 2013 included 15 studies and 1,422,189 participants ([@B18]).

In the last 2 years, nine original population-based studies reported that night-shift work was not associated with cancer development, which have not been included in previously published reviews ([@B19]--[@B26]). We conducted this study to systematically summarize the evidence regarding the associations between night-shift work and cancer risks. We expect to facilitate recognition of the health-related problems among night-shift workers.

Materials and Methods {#s2}
=====================

This systematic review and meta-analysis were conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) ([Table S1](#SM1){ref-type="supplementary-material"}). The study protocol was registered in the online database of PROSPERO (CRD42019138215). This systematic review aimed to answer the medical question of the association between night-shift work and cancer risks by reference to PICOS: (1) study population were night-shift workers; (2) compared to population without night-shift work; (3) the exposure was defined as night-shift work; (4) the outcome of cancer risk was evaluated; (5) observational studies on this topic were included.

Search Strategy
---------------

We used Embase, PubMed, and Web of Science databases to systematically search English language publications issued up to May 31, 2019. The search terms were "carcinoma" or "tumor" or "cancer" or "neoplasm," and "night-shift work" or "night work" or "shift work" or "work schedule tolerance" or "rotating-shift work." The detailed literature search strategy was shown in [Supplementary Box 1](#SM1){ref-type="supplementary-material"}. Two investigators independently searched and then screened the retrieved studies. In addition, we manually screened the reference lists of included studies to collect additional literature.

Inclusion and Exclusion Criteria
--------------------------------

Literature was included based the following criteria: (1) night-shift work was reported. Night-shift work was defined by questionnaire interview or occupational history of those who have ever exposed to shift system (rotating or fixed, forward or backward rotation). The durations that participants have ever engaged in night-shift work were collected by retrospective investigation or follow-up interview. (2) Cancer risk was investigated. (3) Cohort studies, case-control studies, or nested case-control studies. (4) The risk was estimated by odds ratio (OR), risk ratio (RR), or hazard ratio (HR), with 95% confidence interval (CI). (5) For studies reporting overlapping data, the studies newly published or with a larger sample size were included. (6) Publications in English language. Exclusion criteria were (1) studies without sufficient data; (2) studies referring to recurrent cancer.

Quality Assessment
------------------

We assessed the bias risk as low, high, or unclear by verifying the checklist for measuring bias in risk factor studies to counter 10 important sources (domains) of bias ([@B17], [@B27]). The following are domains of bias risk assessment: (1) exposure definition, (2) exposure assessments, (3) reliability of assessments, (4) analysis methods in research (research-specific bias), (5) confusion, (6) attrition, (7) blinding of assessors, (8) selective reporting, (9) funding, and (10) conflict of interest. We then rated the study-level risk of bias as: low (low risk in all major domains and ≥2 of the minor domains), moderate (low risk of bias in ≥4 major and 2 minor domains), or high risk of bias (low risk of bias in \<4 major domains). The detailed information is available in [Supplementary Box 2](#SM1){ref-type="supplementary-material"}.

Data Extraction
---------------

The following items were extracted from eligible studies: (1) first author; (2) publication year; (3) country of participants; (4) study design (cohort studies, case-control studies, or nested case-control studies); (5) number of participants (6) number of cases; (7) duration or person-years of follow-up (8) characteristics of participants (e.g., age, sex, and occupation); (9) years of night- shift work, (10) types of night-shift work; (11) adjusted effect estimates (i.e., OR, RR, and HR) with 95% CI; (12) types of cancers; (13) adjusted variables. Two investigators independently undertook data extraction, and the third author participated in handling debatable issues if necessary.

Statistical Analysis
--------------------

All statistical analyses were done with the Stata14.0 software (Stata Corp, College Station, TX, USA). We preferentially measured the association between night-shift work and all cancer risks *via* the pooled estimates (i.e., OR, RR, and HR) and 95% CI. The Q test along with *I*^2^ statistic was used to identify whether heterogeneity was significant between eligible studies. When *P* \< 0.10 or *I*^2^ \> 50% heterogeneity was considered significant, therefore the random-effect model (Der Simonian-Laird method) meta-analysis was applied, otherwise, the fixed-effect model was used. In addition, subgroup analyses were conducted to stratify the results on specific study design, occupation, night-shift work status, cancer type, and sex. A dose-response meta-analysis was performed to evaluate the risk for cancers per year increase of night-shift work. We established the curve of dose-response relationship using a method proposed by Greenland and Longnecker ([@B28]). In this process, we combined the data from studies that reported the estimate effects of cancer risks with night-shift work at ≥3 quantitative categories. To assess the stability of the results, sensitivity analysis was conducted by sequential removal of each original study. Potential publication bias was assessed by the Begg\'s regression asymmetry test and funnel plot.

Results {#s3}
=======

Literature Search and Study Selection
-------------------------------------

Details of the literature search and screening are shown in [Figure 1](#F1){ref-type="fig"}. A total of 1660 publications were initially retrieved from Embase, PubMed and Web of Science. Among them, 538 duplicate publications were removed. After review of abstracts 1,037 studies were excluded for the following reasons: not human studies (*n* = 53), not studies on cancer and night-shift work (*n* = 713), reviews/editorials/letters (*n* = 271). By full-text review eight studies with overlapping data and 20 studies on sleep patterns were removed. Altogether, this meta-analysis included 57 articles.

![Flow graph of study search and screening.](fonc-10-01006-g0001){#F1}

Characteristics of Included Studies
-----------------------------------

As shown in [Table 1](#T1){ref-type="table"}, our study included 57 articles with 8,477,849 participants (mean age 55 years; 2,560,886 men, 4,220,154 women, and 1,696,809 sex not mentioned) ([@B8], [@B16], [@B19]--[@B26], [@B29]--[@B75]). Of these, 13 studies were from Asia, 26 were from Europe, 16 were from North America, and 2 were from Oceania. The geographic distribution of the studies included are shown in [Figure 2](#F2){ref-type="fig"}. In terms of the participants\' occupations, 11 studies were conducted among nurses, and two were among textile workers. These studies investigated the association between night-shift work and the risk of cancer in the breast (*n* = 26 studies), prostate (*n* = 12), ovaries (*n* = 8), pancreas (*n* = 6), colon/rectum (*n* = 6), lung (*n* = 6), stomach (*n* = 4), skin (*n* = 4), urinary tract (*n* = 3), esophagus (*n* = 3), uterus (*n* = 2), oral cavity (*n* = 2), larynx (*n* = 2), and testes (*n* = 2), as well as non-Hodgkin\'s lymphoma (*n* = 5), and leukemia (*n* = 3).

###### 

Characteristics of included studies.

  **References**                 **Country**   **Study design**   ***N* of participants**   **Age**            ***N* of case**   **Occupations**    **Estimates of risk**   **Cancer**                **Covariates adjusted**                                                                                                                                                                                                                                                                                                                                                                                                                                     **Measurement of night-shift work**
  ------------------------------ ------------- ------------------ ------------------------- ------------------ ----------------- ------------------ ----------------------- ------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------
  Hansen et al. ([@B29])         Denmark       CC                 1,38,301                  NA                 6,281             NA                 OR: 1.5                 Breast cancer             Age, social class, age at birth of first child, age at birth of last child, and number of children                                                                                                                                                                                                                                                                                                                                                          Interview
  Davis et al. ([@B30])          US            CC                 1,606                     NA                 767               NA                 OR: 1.13                Breast cancer             Parity, family history of breast cancer, oral contraceptive use, and recent is continued use of hormone replacement therapy                                                                                                                                                                                                                                                                                                                                 Interview
  Lie et al. ([@B31])            Norway        NCC                44,835                    NA                 412               Nurses             OR: 0.95                Breast cancer             Total duration of work as a nurse and parity                                                                                                                                                                                                                                                                                                                                                                                                                Self-report
  Kubo et al. ([@B32])           Japan         CS                 14,052                    52.14              3                 NA                 RR: 2.3                 Prostatic cancer          Age, study area, family history of prostate cancer, body mass index, smoking, alcohol drinking, job type, physical activity at work, workplace, perceived stress, educational level, and marriage status                                                                                                                                                                                                                                                    Questionnaire
  O\'Leary et al. ([@B33])       US            CC                 1,161                     57.19              480               NA                 OR: 1.04                Breast cancer             Age at reference date, parity, family history, education, and history of benign breast disease                                                                                                                                                                                                                                                                                                                                                              In-house interview
  Schwartzbaum et al. ([@B34])   Sweden        CS                 3,250,787                 NA                 99,263            NA                 OR: 1                   All cancer                Age, socioeconomic status, occupational position, and county of residence of residence                                                                                                                                                                                                                                                                                                                                                                      Personal interviews
  Viswanathan et al. ([@B4])     US            CS                 53,487                    53.51              210               Nurses             RR: 1                   Uterus cancer             Age, age at menarche, age at menopause, parity, BMI, oral contraceptive use, use and duration of post-menopausal hormones, hypertension, diabetes, and smoking                                                                                                                                                                                                                                                                                              Questionnaire
  Marino et al. ([@B35])         US            CC                 2,125                     NA                 812               NA                 OR: 1.2                 Ovarian cancer            Multivariable adjustment                                                                                                                                                                                                                                                                                                                                                                                                                                    Interviews
  Lahti et al. ([@B36])          Finland       CS                 1,669,272                 NA                 3,813             NA                 RR: 1.1                 Non-Hodgkin\'s lymphoma   Age, social class, and cohort period                                                                                                                                                                                                                                                                                                                                                                                                                        Questionnaire
  Pronk et al. ([@B37])          China         CS                 73,049                    52.50              717               NA                 HR: 0.9                 Breast cancer             Age, education, family history of breast cancer, number of pregnancies, age at first birth, and occupational physical activity                                                                                                                                                                                                                                                                                                                              Interview
  Chu et al. ([@B38])            China         NCC                2,023                     NA                 408               NA                 OR: 2.54                Breast cancer             Potential cofounders                                                                                                                                                                                                                                                                                                                                                                                                                                        Interview
  Pesch et al. ([@B39])          Germany       CC                 1,749                     NA                 713               NA                 OR: 0.64                Breast cancer             A potential selection bias using bootstrapping, family history of breast cancer, hormone replacement use, and number of mammograms                                                                                                                                                                                                                                                                                                                          Interview
  Poole et al. ([@B40])          US            CS                 71,297                    57.21              309               Nurses             HR: 1.14                Ovarian cancer            Age, duration of oral contraceptive use, parity, BMI, smoking status, tubal ligation history, menopausal status, family history of ovarian cancer, duration of breast treating, and cohort                                                                                                                                                                                                                                                                  Questionnaire
  Kubo et al. ([@B41])           Japan         CS                 4,995 (*SD* = 3.6)        55.5               17                NA                 RR: 1.79                Prostate cancer           Age, body mass index, alcohol intake, smoking, exercise, and marital status                                                                                                                                                                                                                                                                                                                                                                                 Questionnaire
  Lie et al. ([@B26])            Norway        NCC                1,594                     54.46              492               Nurses             OR: 1.2                 Breast cancer             Age, period of diagnosis, parity, family history of breast cancer in mother or sister (no/yes), and frequency of alcohol consumption at time of diagnosis                                                                                                                                                                                                                                                                                                   Telephone interview
  Hansen et al. ([@B29])         Denmark       CS                 18,551                    NA                 132               Women military     OR: 1.4                 Breast cancer             Age, hormone replacement therapy, number of childbirths, age at menarche, years of education, occasional sunbathing frequency, and tobacco smoking status                                                                                                                                                                                                                                                                                                   Questionnaire
  Parent et al. ([@B42])         Canada        CC                 3,549                     59.18              216               NA                 OR: 1.76                Lung cancer               None                                                                                                                                                                                                                                                                                                                                                                                                                                                        Interview
  Natti et al. ([@B43])          Finland       CS                 3,096                     36.68              51                NA                 HR: 1.78                All cancer                Age, and smoking status, demographics, and health- and work-related factors                                                                                                                                                                                                                                                                                                                                                                                 interview
  Lin et al. ([@B44])            Japan         CS                 22,224                    52.19              5                 Industry           RR: 0.61                Pancreatic cancer         Age, body mass index, history of diabetes, alcohol drinking, cigarette smoking, perceived stress, and sleep time                                                                                                                                                                                                                                                                                                                                            Questionnaire
  Knutsson et al. ([@B45])       Sweden        CS                 4,036                     42.31              94                NA                 HR: 2.02                Breast cancer             Number of children, alcohol consumption, BMI, height, weight, waist, hip circumference, educational level, smoking menopausal status, status of oral contraceptive use, and hormones other than contraceptives                                                                                                                                                                                                                                              Questionnaire
  Bhatti et al. ([@B46])         US            CC                 3,322                     NA                 1,101             NA                 OR: 1.24                Ovarian cancer            Age at reference, county, reference year, duration of oral contraceptive use, number of full-term pregnancies, and BMI at age 30                                                                                                                                                                                                                                                                                                                            Interviews self-reported
  Fritschi et al. ([@B47])       Australian    CC                 2,994                     NA                 1,202             NA                 OR: 1.16                Breast cancer             Night shift work                                                                                                                                                                                                                                                                                                                                                                                                                                            Questionnaire
  Menegaux et al. ([@B48])       France        CC                 2,549                     NA                 1,232             NA                 OR: 1.27                Breast cancer             Age, study area, parity, age at first full term pregnancy, age at menarche, family history of breast cancer, current hormonal replacement therapy, BMI, tobacco, and alcohol                                                                                                                                                                                                                                                                                Interview
  Grundy et al. ([@B49])         Canada        CC                 2,312                     57.03              1,034             NA                 OR: 0.95                Breast cancer             Years of night shift history                                                                                                                                                                                                                                                                                                                                                                                                                                Questionnaire
  Rabstein et al. ([@B50])       Germany       CC                 1,749                     NA                 857               NA                 OR: 1.01                Breast cancer             Family history of breast cancer, hormone replacement use, number of mammograms, and estrogen receptor status                                                                                                                                                                                                                                                                                                                                                Interview
  Koppes et al. ([@B51])         Netherland    CS                 5,71,446                  NA                 2,414             Employed women     HR: 1.04                Breast cancer             Age, origin, children in household education, occupation, and job tenure (years)                                                                                                                                                                                                                                                                                                                                                                            Interview
  Gapstur et al. ([@B52])        US            CS                 3,05,057                  51.44                                NA                 RR: 1.08                Prostate cancer           Age, race, education, BMI, smoking status, family history of prostate cancer, and painful/frequent urination                                                                                                                                                                                                                                                                                                                                                Questionnaire
  Carter et al. ([@B53])         US            CS                 1,61,004                  50.28              1,227             Employed women     RR: 1.27                Ovarian cancer            Oral contraceptive use, age at menarche and menopause, tubal ligation, parity, post-menopausal estrogen use, race, family history of breast/ovarian cancers, exercise, BMI, and height                                                                                                                                                                                                                                                                      Questionnaire
  Yong et al. ([@B54])           Germany       CS                 27,828                    40.05              1,073             Chemical workers   HR: 1.04                All cancer                Age, job level, cigarette smoking, and employment duration in categories                                                                                                                                                                                                                                                                                                                                                                                    Questionnaire
  Ren et al. ([@B55])            China         CC                 1,454                     NA                 712               NA                 OR: 1.34                Breast cancer             Age, education, BMI, marital status, age at menarche, menopausal status, parity, activity, breastfeeding, family history of breast cancer, and other sleep factors                                                                                                                                                                                                                                                                                          Database
  Datta et al. ([@B56])          India         CC                 150                       NA                 50                NA                 OR: 1.51                Breast cancer             Age, obesity factors, and food habits                                                                                                                                                                                                                                                                                                                                                                                                                       Interview
  Kwon et al. ([@B57])           China         CS                 2,67,400                  54.01              670               Textile workers    HR: 0.76                Lung cancer               Age, smoking, parity, and endotoxin                                                                                                                                                                                                                                                                                                                                                                                                                         Factory record
  Gu et al. ([@B58])             US            CS                 71,857                    63.98              4,235             Nurses             HR: 1.03                All cancer                Age, alcohol consumption, physical exercise, multivitamin use, menopausal status and post-menopausal hormone use, physical exam in the past 2 years, healthy eating score (quintiles), smoking status, and pack-years; BMI and husband\'s education                                                                                                                                                                                                         Questionnaire
  Hammer et al. ([@B59])         Germany       CS                 27,828                    NA                 337               NA                 HR: 0.93                Prostatic cancer          Age and professional status                                                                                                                                                                                                                                                                                                                                                                                                                                 Questionnaire
  Lin et al. ([@B60])            Japan         CS                 22,224                    52.00                                NA                 HR: 0.86                Biliary tract cancer      Age, BMI, history of cholelithiasis, history of diabetes, cigarette smoking, alcohol drinking, perceived stress, and sleep time                                                                                                                                                                                                                                                                                                                             Questionnaire
  Akerstedt et al. ([@B61])      Sweden        CS                 12,322                    51.50              463               NA                 HR: 0.96                Breast cancer             Age, education level, tobacco consumption, BMI, having children, coffee consumption, previous cancer, and use of hormones including oral contraceptives physical activity alcohol consumption                                                                                                                                                                                                                                                               Interview
  Li et al. ([@B62])             China         NCC                6,489                     53.40              387               Textile workers    HR: 0.99                Breast cancer             Age at the beginning of follow-up                                                                                                                                                                                                                                                                                                                                                                                                                           Factory records and in-person interviews
  Papantoniou et al. ([@B63])    Spanish       CC                 3,486                     57.37              1,505             NA                 OR: 1.21                Breast cancer             Age, center, educational level, parity, menopausal status, family history of breast cancer, BMI, smoking status, oral contraceptive use, leisure time physical activity, alcohol consumption, and sleep duration                                                                                                                                                                                                                                            Interview
  Santi et al. ([@B64])          Canada        CC                 1,519                     58.00              744               Nurses             OR: 1.39                Breast cancer             Age, family history, level of education, oral contraception use, alcohol consumption, number of births, and age of first menstruation                                                                                                                                                                                                                                                                                                                       Questionnaire
  Wang et al. ([@B65])           China         CC                 1,454                     47.50              661               NA                 OR: 1.34                Breast cancer             Age, education, BMI, age at menarche, menopausal status, parity, physical activity, breast-feeding, family history of breast cancer, and other sleep factors (24-h sleep duration, night-shift work, or daytime napping)                                                                                                                                                                                                                                    Interviews
  Travis et al. ([@B16])         UK            CS                 7,95,850                  65.28              4,809             NA                 RR: 1                   Breast cancer             Socioeconomic status, parity and age at first birth, BMI, alcohol intake, strenuous physical activity, family history of breast cancer, age at menarche, oral contraceptive use, smoking, living, with a partner, and use of menopausal hormone therapy                                                                                                                                                                                                     Database
  Heckman et al. ([@B66])        US            CS                 74,323                    46.67              67                Nurses             HR: 1                   Skin cancer               Years of shift work, hours of sleep, sleep adequacy, sleepy days per week, snoring, restless legs syndrome, family history of melanoma, hours spent in sun, number of severe sunburns, sunburn severity, artificial tanning frequency, annual UV at residence, moles on lower legs, natural hair color in adolescence, marital status, financial status, BMI, physical activity, smoking status, menopausal status, hormone use, and healthy eating index   Questionnaire
  Dickerman et al. ([@B67])      Switzerland   CS                 11,370                    40 (*SD* = 12.1)   2                 NA                 HR: 0.5                 Prostatic cancer          Age, education, BMI, physical activity, social class, smoking status, alcohol use, snoring, and zygosity                                                                                                                                                                                                                                                                                                                                                    Questionnaire
  Gyarmati et al. ([@B68])       Spain         CC                 2,855                     62.70              278               NA                 OR: 1.1                 Stomach cancer            Age, sex, educational level, cent re, BMI, cigarette smoking status, family history, and physical activity level                                                                                                                                                                                                                                                                                                                                            Interviews
  Bai et al. ([@B69])            China         CS                 25,377                    62.72              108               NA                 HR: 1.19                All cancer                Age, BMI, family history of cancer, alcohol drinking and smoking status, number of children, menopausal status, hormone replacement therapy, and contraception status                                                                                                                                                                                                                                                                                       Questionnaire
  Costas et al. ([@B70])         Spain         CC                 2,049                     72.00              304               NA                 OR: 1.06                Leukemic cancer           Adjusted for region, age, sex, worked on a farm, family history of hematologic malignancies, body mass index, tobacco consumption, sleep problems, and education                                                                                                                                                                                                                                                                                            Interview
  Wegrzyn et al. ([@B71])        US            CS                 1,93,075                  54.72              5,544             Nurses             HR: 1.01                Breast cancer             Age, height, BMI, adolescent body size, age at menarche, age at first birth and parity combined, breast feeding, type of menopause and age duration mammography use activity, and current alcohol consumption, physical history of benign breast disease, family history of breast cancer, hormone therapy, and first-degree progesterone menopausal duration of estrogen and hormone therapy                                                               Database
  Vistisen et al. ([@B23])       Denmark       CS                 1,55,540                  39.40              1,245             Nurses             RR: 0.9                 Breast cancer             Calendar year, age, age at birth of first child, number of births, family history of breast cancer or ovarian cancer, oral contraception, hormone replacement therapy, other sex hormones, medication, mammography screening attendance, and highest family educational level                                                                                                                                                                               Database
  Jorgensen et al. ([@B72])      Denmark       CS                 28,731                    44.00              73                Nurses             HR: 1.05                All cancer                Age, smoking, pack-years, physical activity, BMI, alcohol consumption, diet (vegetables, fruit and fatty meat consumption), pre-existing diseases, health, stressful work environment, marital status, and female reproductive factors                                                                                                                                                                                                                      Interviews self-reported
  Åkerstedt et al. ([@B24])      Sweden        CS                 12,322                    51.50              454               NA                 HR: 0.91                Prostatic cancer          Age, education level, tobacco consumption, BMI, having children, coffee consumption, and previous cancer                                                                                                                                                                                                                                                                                                                                                    Telephone interview
  Behrens et al. ([@B25])        Germany       CS                 1,757                     66.80              76                NA                 HR: 2.18                Prostatic cancer          Age at event and adjusted for smoking (never, former smoker, current smoker) and family history of prostate cancer                                                                                                                                                                                                                                                                                                                                          Questionnaire
  Tse et al. ([@B73])            China         CC                 833                       68.82                                NA                 OR: 1.76                Prostatic cancer          Age at interview, marital status, unemployment status, family prostate cancer history, consumption of deeply fried food, consumption of pickled vegetable, and green tea drinking habits                                                                                                                                                                                                                                                                    Questionnaire
  Papantoniou et al. ([@B20])    US            CS                 1,90,810                  42.87              930               Nurses             HR: 1.04                Colorectal cancer         Age, height, BMI, educational level, menopausal status, menopausal hormone therapy, first-degree family history of colorectal cancer, alcohol consumption, physical activity, smoking status, and medication                                                                                                                                                                                                                                                Questionnaires
  Wendeu-Foyet et al. ([@B21])   France        CC                 1,693                     NA                 818               NA                 OR: 0.97                Prostatic cancer          Adjusted for age, family history of prostate cancer, race, and education level                                                                                                                                                                                                                                                                                                                                                                              Self-report
  Walasa et al. ([@B22])         Australia     CC                 760                       NA                 350               NA                 OR: 1.06                Colorectal cancer         Potential demographic, lifestyle, and medical confounders                                                                                                                                                                                                                                                                                                                                                                                                   Questionnaire
  Jones et al. ([@B74])          UK            CS                 1,02,869                  45                 2,059             NA                 HR: 1                   Breast cancer             Age, time since recruitment, birth cohort, benign breast disease, family history of breast cancer in 1st degree relatives, socio-economic score, birth weight, height, BMI, age at first pregnancy, parity, breast-feeding, current oral contraceptive use before menopause, alcohol consumption, age started smoking, physical activity, etc.                                                                                                              Questionnaire
  Leung et al. ([@B19])          Canada        CC                 1,402                     NA                 202               NA                 OR: 1.14                Ovarian cancer            Adjusted for age (continuous), education (\< high school, high school, college/technical, University undergraduate, University graduate), and parity (nulliparous, 1, 2, ≥3 full-term births)                                                                                                                                                                                                                                                               Interview

*BMI, body mass index; CC, case-control study; CS, cohort study; HR, hazard ratio; NCC, nest case-control study; N, number; NA, not available; OR, odds ratio; RR, relative risk*.

![Geographic distribution of included studies.](fonc-10-01006-g0002){#F2}

The quality assessment of original studies showed that no study had an overall low risk of bias and 44 studies were of moderate risk \[([@B4], [@B16], [@B19]--[@B21], [@B23]--[@B26], [@B29], [@B31], [@B32], [@B36], [@B37], [@B39]--[@B43], [@B46], [@B48]--[@B53], [@B57]--[@B60], [@B62], [@B63], [@B65]--[@B71], [@B73]--[@B75]); [Table S2](#SM1){ref-type="supplementary-material"}\]. Thirty-one studies were considered to have a low risk of bias in how they defined night-shift work ([@B4], [@B20], [@B21], [@B23], [@B24], [@B26], [@B29], [@B32], [@B35]--[@B37], [@B41], [@B43], [@B46], [@B48], [@B50]--[@B53], [@B58]--[@B60], [@B63], [@B65], [@B67]--[@B72], [@B74]). For method of exposure measurement, only eight studies showed low risk ([@B20], [@B23], [@B36], [@B41], [@B57]--[@B59], [@B69]). Thirty-one studies had a low risk of bias for reliability of exposure assessment ([@B4], [@B16], [@B19]--[@B21], [@B23], [@B29]--[@B31], [@B33], [@B35], [@B37]--[@B39], [@B41], [@B45], [@B48], [@B51], [@B55], [@B57]--[@B61], [@B65], [@B66], [@B68]--[@B70], [@B73], [@B75]). Forty studies had low risk of bias for the analysis domain ([@B4], [@B16], [@B19], [@B20], [@B22], [@B23], [@B26], [@B29], [@B31], [@B35]--[@B37], [@B39]--[@B42], [@B44], [@B46]--[@B52], [@B55], [@B57], [@B59], [@B61]--[@B74]), and 49 reported a low risk in adjustment for confounding factors ([@B4], [@B16], [@B20], [@B21], [@B23]--[@B26], [@B29], [@B32], [@B35]--[@B43], [@B45]--[@B55], [@B57]--[@B75]). For the aspect of attrition domain, 27 studies had low risk in bias ([@B4], [@B19], [@B23]--[@B26], [@B31]--[@B33], [@B37], [@B40]--[@B43], [@B46], [@B48], [@B50], [@B52], [@B56]--[@B58], [@B60], [@B61], [@B65], [@B66], [@B72], [@B74], [@B75]). Nineteen studies were considered a low risk of bias for blinding ([@B19], [@B29], [@B31], [@B32], [@B34], [@B37]--[@B40], [@B42], [@B43], [@B47], [@B49], [@B50], [@B58], [@B62], [@B63], [@B69], [@B70], [@B75]). Fifty-two studies had a low risk in the aspect of selective reporting ([@B4], [@B16], [@B19]--[@B24], [@B26], [@B29]--[@B45], [@B48]--[@B54], [@B56]--[@B75]). Forty-six studies reported that sponsors had no role in conduct ([@B4], [@B16], [@B19]--[@B26], [@B26], [@B29], [@B31]--[@B36], [@B39]--[@B41], [@B43], [@B45]--[@B49], [@B51]--[@B63], [@B65]--[@B75]) and authors from 51 articles confirmed no conflict of interest ([@B4], [@B16], [@B19]--[@B26], [@B29], [@B31]--[@B75]).

Quantitative Meta-Analyses
--------------------------

As shown in [Table 2](#T2){ref-type="table"}, the risks of breast cancer (pooled *OR* = 1.009, 95% CI = 0.984--1.033), prostate cancer (pooled *OR* = 1.027, 95% CI = 0.982--1.071), ovarian cancer (pooled *OR* = 1.027, 95% CI = 0.942--1.113), pancreatic cancer (pooled *OR* = 1.007, 95% CI = 0.910--1.104), colorectal cancer (pooled *OR* = 1.016, 95% CI = 0.964--1.068) were not significantly associated with night-shift work. Besides, the pooled results, which were from small number of original studies, showed that stomach cancer, esophageal cancer, leukemia, oral cancer, uterine cancer, laryngeal cancer, testicular cancer, and non-Hodgkin lymphoma were not associated with night-shift work. Combination of three original studies showed that night-shift work increased the risk of urinary cancer. However, decreased risks of lung cancer and skin cancer were observed on the basis of pooled results of six and four studies, respectively.

###### 

Meta-analyses on the associations between night-shift work and each type of cancers.

  **Types of cancers**   ***N***   **OR**   **95% CI**       **Heterogeneity (*I*^**2**^, %)**
  ---------------------- --------- -------- ---------------- -----------------------------------
  Breast cancer          26        1.009    (0.984, 1.033)   45.7
  Prostate cancer        12        1.027    (0.982, 1.071)   52.3
  Ovarian cancer         8         1.027    (0.942, 1.113)   33.3
  Pancreatic cancer      6         1.007    (0.910, 1.104)   3.2
  Colorectal cancer      6         1.016    (0.964, 1.068)   52.2
  Lung cancer            6         0.949    (0.903, 0.996)   52
  Non-Hodgkin\'s lymph   5         1.046    (0.994, 1.098)   30.5
  Stomach cancer         4         1.064    (0.971, 1.157)   0
  Skin cancer            4         0.916    (0.879, 0.953)   29.4
  Urinary organs         3         1.091    (1.019, 1.163)   0
  Esophagus cancer       3         0.812    (0.616, 1.008)   32.1
  Leukemia               3         0.983    (0.838, 1.127)   0
  Uterus cancer          2         0.984    (0.844, 1.123)   31.9
  Oral cancer            2         0.897    (0.717, 1.077)   0
  Larynx cancer          2         1.003    (0.784, 1.222)   0
  Testis cancer          2         0.9      (0.636, 1.164)   0

*OR, odds ratio; CI, confidence interval; N, number of included studies*.

Subgroup Analysis
-----------------

As subgroup analyses on the association between night-shift work and combined risk for cancers ([Table 3](#T3){ref-type="table"}), no significant associations were observed in cohort studies (pooled *OR* = 0.996, 95% CI = 0.982--1.011) and nest case-control studies (pooled *OR* = 0.960, 95% CI = 0.887--1.032). However, the pooled result from case-control studies was statistically significant (pooled *OR* = 1.176, 95% CI =1.122--1.230). With regard to sex, night-shift work was only associated with increased risk of cancer among men (pooled *OR* = 1.033, 95% CI = 1.010--1.055).

###### 

Subgroup meta-analyses on the associations between night-shift work and combined risk for cancers.

  **Groups**                      ***N***   **OR**   **95% CI**       **Heterogeneity (*I*^**2**^, %)**
  ------------------------------- --------- -------- ---------------- -----------------------------------
  **Types of night-shift work**                                       
     Fixed                        8         0.880    (0.746, 1.014)   0.0
     Rotating                     15        0.982    (0.960, 1.004)   41.6
  **Study designs**                                                   
     Cohort studies               32        0.996    (0982, 1.011)    41.2
     Case-control studies         21        1.176    (1.122, 1.230)   47.2
     Nest case-control studies    4         0.960    (0.887, 1.032)   18.1
  **Sex**                                                             
     Women                        41        0.989    (0.972, 1.006)   46.7
     Men                          17        1.033    (1.010, 1.055)   53.1
  **Occupation**                                                      
     Nurses                       11        0.979    (0.958, 1.001)   40.8
     Textile workers              2         0.885    (0.826, 0.944)   0.0
  **Region**                                                          
     Asia                         13        0.949    (0.899, 0.998)   39.4
     Europe                       26        1.019    (1.000, 1.037)   41.3
     North America                16        0.999    (0.978, 1.021)   59.1
     Oceania                      2         1.140    (0.957, 1.323)   0.0

*OR, odds ratio; CI, confidence interval; N, number of included studies*.

For types of night-shift work, neither rotating nor fixed night-shift work was associated with an increased risk of cancer, with pooled ORs 0.982 (95% CI = 0.960--1.004), and 0.880 (95% CI = 0.746--1.014), respectively. The association between night-shift work and cancer risks were also analyzed among occupational groups. Night-shift work was associated with a decreased risk of cancers among textile workers, while no significant association was found for nurses.

We included 13 original studies from Asia, 26 from Europe, 16 from North America, and 2 from Oceania. Subgroup analyses indicated that night-shift work was associated with an increased risk for cancers in Europe, and a decreased risk in Asia, while no significant associations were observed in America or Oceania.

Dose Response Meta-Analysis
---------------------------

For studies that reported more than one category of durations of night-shift work, we assessed whether the risk of cancer increased in a dose-response manner per year night-shift work. As shown in [Figure 3](#F3){ref-type="fig"}, a dose-response curve was established, in which the solid line is a curve model established by the dose response meta-analysis, while the dotted line represents a reference of linear model. The result indicated that, for every 1 year increase of night-shift work, there is no increased risk for cancer (χ^2^ = 3.34, *P* = 0.067).

![Dose-response analysis on night-shift work durations and cancer risk.](fonc-10-01006-g0003){#F3}

In addition, we validated this finding with comparisons of cancer risks among individuals with different classifications of night work duration (0--5, 6--10, 11--15, 16--20, 21--25, and ≥26 years). Taking all eligible studies together, night-shift work did not increase the risk of cancer in any group of night workers ([Figure 4](#F4){ref-type="fig"} and [Table S3](#SM1){ref-type="supplementary-material"}).

![Analysis on classifications of night-shift work duration.](fonc-10-01006-g0004){#F4}

Heterogeneity Analysis
----------------------

The *Q*-test and *I*^2^ statistics were used to assess heterogeneity across included studies. No obvious heterogeneity was observed in the overall analyses, while heterogeneity was found in four subgroup analyses (i.e., men, North America area, prostate cancer, lung cancer, and colorectal cancer).

Sensitivity Analysis and Publication Bias
-----------------------------------------

We performed the sensitivity analysis by omitting one study at a time, and recalculated the pooled OR of the remaining studies. As shown in [Figure S1](#SM1){ref-type="supplementary-material"}, no significant alteration was observed by removal of any single study except when the study of Poole et al. was removed (pooled *OR* = 1.020, 95% CI = 1.000--1.050) ([@B40]).

The Begg\'s test and funnel plot analysis ([Figure 5](#F5){ref-type="fig"}) revealed a significant publication bias (*z* = 3.45, *P* = 0.001). Complete details in the underlying case-control studies that manifested insignificant associations might not have been fully published. In order to eliminate the fallacy introduced by publication bias, we performed a trim and fill analysis, in which the negative insignificant studies were filled ([Figure S2](#SM1){ref-type="supplementary-material"}). The filled results showed that night-shift work was not associated with breast cancer (Filled *OR* = 1.018, 95% CI = 0.965--1.074), prostate cancer (Filled *OR* = 1.066, 95% CI = 0.906--1.254); pancreatic cancer (Filled *OR* = 1.051, 95% CI = 0.919--1.203), ovarian cancer (Filled *OR* = 1.050, 95% CI = 0.948--1.164), lung cancer (Filled *OR* = 0.957, 95% CI = 0.861--1.065), or colorectal cancer (Filled *OR* = 1.091, 95% CI = 0.976--1.220). Meanwhile, the trim and fill analysis showed a significant association between night-shift work and skin cancer (Filled *OR* = 0.928, 95% CI = 0.875--0.985). In addition, trim and fill analysis showed insignificant results in Asians (Filled *OR* = 1.002, 95% CI = 0.906--1.108) and Americans (Filled *OR* = 1.016, 95% CI = 0.961--1.075), and a significant result among Europeans (Filled *OR* = 1.058, 95% CI = 1.011--1.106).

![Funnel plot for publication bias analysis.](fonc-10-01006-g0005){#F5}

Discussion {#s4}
==========

This updated systematic review included 57 publications with 8,477,849 participants. Our meta-analysis found an insignificant association between night-shift work and cancer risks. No increased risk for cancer was identified among female night-shift workers as well. Neither rotating night-shift workers nor fixed night-shift workers had an increased risk for cancer. However, analysis on geographical distribution showed an increased risk for cancer among night-shift workers in Europe.

As a common concern in case-control studies, recall bias might have been introduced into our study during the measurement of night work. This bias represents a major threat to the validity when the participants were investigated with self-reported questionnaires. In order to eliminate potential recall bias resulting from previous case-control studies on the association between night-shift work and cancer risks, we synthesized the data from cohort studies in which recall bias can be effectively controlled. Consequently, an insignificant association was noted again.

Researchers have proposed several underlying mechanism of cancer risks induced by night-shift work. Night-shift workers usually experience unnatural light at night, which reduces the release of melatonin ([@B76]). As a kind of methoxy indole compound secreted by the pineal gland, melatonin shows a variety of anti-tumor effects, such as anti-oxidant, anti-apoptosis, anti-angiogenesis, as well as modulation of hormones and immunity ([@B77], [@B78]). It has been demonstrated that melatonin plays critical roles in breast, ovarian, endometrial, prostate, lung, and gastrointestinal cancers ([@B79]--[@B86]). Decreased melatonin leads to an imbalance of inflammatory cytokine secretions, mutagenesis, and oxidative damage, which likely results in the progression of various cancers ([@B87]). Suppression of melatonin also induces the aberrant secretion of testosterone and estrogen which increases the risks of prostate, endometrial, ovarian, uterine, and breast cancers ([@B88]).

In addition, tumor suppression is a clock-controlled process. Night-shift workers are exposed to dysfunction of circadian genes that is understood to play a role in DNA repair and carcinogen metabolism ([@B89]--[@B91]). The disruption of the circadian time organization contributes to cancer development. The "clock" genes are known to be directly involved in the regulation of prostate tumorigenesis.

The intensity and duration, as well as the type of night-shift work may influence the effect on cancer risk. As other published systematic reviews, our study included all eligible studies on night-shift work (i.e., fixed and rotating night-shift work) in retrospective and prospective studies. Our subgroup analyses showed that neither fixed nor rotating night-shift work is associated with cancer risk. In addition, night-shift work has little association with cancer risk in spite of the variation of night work duration.

Surprisingly, our subgroup analysis demonstrated that night-shift work is associated with a reduction of cancer risk in Asians. It has been explained that Asian workers have different lifestyles and genotypes compared with Europeans and Americans ([@B2]). This finding, as well as the negative association between night-shift work and lung and skin cancers might result from publication bias or relatively small number of included studies.

The present study has more strengths than previous systematic reviews and meta-analyses on the same topic. As a newly released update, this study included many more eligible articles, among them nine studies were that were included in a meta-analysis for the first time. The larger populations enrolled in these studies could produce more accurate effect size at a higher statistical power. Furthermore, our study was conducted on the basis of strict inclusion and exclusion criteria. We rigorously included original data on night-shift work and excluded ineligible studies included in previous meta-analyses. These studies were conducted on work classifications, duration of sleep, sleep disturbance, and light at night. We checked all the database of original studies on night-shift work, and removed three studies on colorectal cancer ([@B58], [@B92], [@B93]), one study on lung cancer ([@B94]), one study on ovarian cancer ([@B40]), and five studies on breast cancer ([@B3], [@B58], [@B95]--[@B97]) because these studies reported overlapping data from the Nurses\' Health Study (NHS) and/or NHS2. As a preferred solution, the newly published studies were included in our meta-analysis ([@B20], [@B58]).

Limitations
-----------

Our study has some limitations which might sometimes exist in common systematic reviews. First, even though we searched three most commonly used databases, there is potential studies that were missed, especially published in local languages. A slightly different search by a reviewer can lead to very different initial results, which should also cause some caution. Second, we observed moderate heterogeneity in the subgroup analyses of the cohort study group, case-control study group, women, European region, Asian region, breast cancer, lung cancer, and endocrine cancers. The data from case-control studies might be biased by different methods of night-shift work measurement. Third, due to the lack of information on occupations of participants and measurement of night-shift work, these variables were not taken into account in the adjustment model. Moreover, publication bias was statistically positive, which could hinder the quality of this study. We use a trim and fill approach, and no substantial differences were obtained. Our combination of the results on all type of cancers may lead to the neglect of cancer-specific differences. As is known, cancers with stronger hormone components appear to be substantially different from those with less hormone control. In addition, we reported the results for ever vs. never night-shift work. There are many other indicators in night-shift work studies that track exposure in a more variable way. It is possible that the use of more differentiated exposure metrics, such as frequency or intensity of night-shift work, might lead to other results.

In conclusion, this systematic review of 57 observational studies did not find an overall association between ever-exposure to night-shift work and the risk of breast, prostate ovarian, pancreatic, colorectal, non-Hodgkin\'s lymph, and stomach cancers. With regard to sex, night-shift work was only associated with increased risk of cancer among men.
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